Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowOxford BioSignals Medical is expected to announce an expansion of its
Oxford has seven employees.
Formed in 2000, Oxford BioSignals began its life when research scientists in the
In 2003, Rolls-Royce signed a 10-year strategic purchase agreement and began testing the technology in
So the company reconfigured the technology to simultaneously observe the results of medical machines that observe heart rates, blood pressure, breathing rates and the saturation of oxygen in the blood. Along the way, Oxford BioSignals attracted $20 million in venture capital from a syndicate of
The company conducted a clinical trial at
Please enable JavaScript to view this content.